<DOC>
	<DOCNO>NCT00768222</DOCNO>
	<brief_summary>This 90-day study evaluate cosmetic outcome Surgical Site Infection approximately 100 patient 6 center China undergo schedule modified radical mastectomy breast cancer .</brief_summary>
	<brief_title>Coated VICRYL* Plus Suture Compared Chinese Silk Scheduled Breast Cancer Surgery</brief_title>
	<detailed_description>Patients evaluate post-procedure Days 3 , 5 , 7 , 12 , 30 90 cosmetic outcome surgical site infection .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Triclosan</mesh_term>
	<criteria>18 year age old write informed consent Scheduled modify radical mastectomy Surgical wound classify Class I/Clean use CDC SSI Surgical Wound Classification Unable give consent unlikely comply study requirement complete 90day follow visit Undergoing surgery modify radical mastectomy immediate breast reconstruction , cosmetic breast operation , reduction , expansion , insertion prothesis , duct ectasia infective breast disease implant Surgical wound classify Class II , III IV use CDC SSI Surgical Wound Classification Has inflammatory cancer skin ulceration Has know allergy intolerance triclosan Has compromise wound heal chronic immune deficiency , example diabetes , prolong steroid use , AIDS substance abuse Has serious heart and/or lung disease Has skin scar history family history Has direct relationship involvement study direction investigator center Received experimental drug device within 30 day prior planned start treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>wound healing</keyword>
</DOC>